SCHEMBL30117871

SCHEMBL30117871

O=C(NCCCO)c1cnn2ccccc12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.60
KDM4E B2RXH2 6/20 0.60
NPC1 O15118 5/20 0.60
RAB9A P51151 5/20 0.60
SMN1; SMN2 Q16637 4/20 0.60
HTT P42858 2/20 0.60
HSD17B10 Q99714 3/20 0.59
LMNA P02545 1/20 0.56
USP2 O75604 1/20 0.56
TSHR P16473 1/20 0.56
DRD2 P14416 5/20 0.56
DRD4 P21917 5/20 0.56
DRD3 P35462 5/20 0.56
DRD1 P21728 4/20 0.56
HTR2A P28223 3/20 0.55
HTR1A P08908 1/20 0.55
ADRA1D P25100 1/20 0.55
HTR2C P28335 1/20 0.55
ADRA1A P35348 1/20 0.55
ADRA1B P35368 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9282686 0.86 ALDH1A1 (0.66) ALDH1A1KDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL30117833 0.83 DRD2 (0.69) ALDH1A1KDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL17642088 0.81 KDM4E (0.43) ALDH1A1KDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL30117755 0.80 DRD2 (0.66) ALDH1A1KDM4ESMN1; SMN2HSD17B10LMNA
SCHEMBL3085478 0.80 EPHB3 (0.62) ALDH1A1KDM4ENPC1RAB9ASMN1; SMN2
Hydrochloric Acid SCHEMBL17633033 0.80 KDM4E (0.42) ALDH1A1KDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL30269996 0.80 ALDH1A1 (0.81) ALDH1A1KDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL30407121 0.78 ALDH1A1 (0.64) ALDH1A1KDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL19409093 0.78 F11 (0.46) ALDH1A1KDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL6121120 0.77 NPC1 (0.63) ALDH1A1KDM4ENPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2903978-B1 GDF-8 INHIBITORS RIGEL PHARMACEUTICALS INC (US) 2022-12-07 EP claimed